Barclays analyst Dan Levy raised the firm’s price target on Visteon (VC) to $120 from $115 and keeps an Equal Weight rating on the shares. The company reported a Q2 beat driven by margin, the analyst tells investors in a research note. The firm remains on the sidelines pending a pickup in growth.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on VC:
- Visteon Reports Strong Q2 2025 Results, Updates Guidance
- Visteon price target raised to $130 from $110 at BofA
- Visteon Reports Strong Q2 2025 Financial Results
- Visteon narrows FY25 revenue view to $3.7B-$3.85B from $3.65B-$3.85B
- Visteon resumes share repurchases, initiates 27.5c per share quarterly dividend
